Thought Leadership
A searchable library for all Cerner Enviza thought leadership across
multiple channels. For clinical publications please click here.
Latest
Evolution of the immune checkpoint inhibitor market landscape in China
Recent regulatory developments and increasing domestic competition in China are now shaping development strategy for global companies
Blog
Stigma: A vicious circle of burden for sufferers
The experience of people suffering from irritable bowel syndrome (IBS) is often fraught with stigma, confusion, embarrassment, belittlement, and loneliness. Cerner Enviza conducted qualitative research with IBS sufferers in UK, US, Germany and China to learn more about the experiences of living with IBS.
Podcast
Episode 5: Let's get real - Women in Leadership
Listen to this podcast where Sepi Varon and Lulu Lee share tips on effective communication to help advance your career.
Webinar
ASCO 2022 preview webinar: Key trials with high clinical and commercial impact
Join us for a preview ASCO webinar where a panel of experts will share their perspectives on the potentially practice-changing results in breast cancer, novel approaches in Non-Hodgkin Lymphoma and Myelofibrosis, and a series of exciting MOAs in early-stage trials.
Infographic
Evolution of the immune checkpoint inhibitor market landscape in China
Recent regulatory developments and increasing domestic competition in China are now shaping development strategy for global companies
Newsletter
Oncology Newsletter │November 2022
Winning in the early-stage NSCLC immunotherapy landscape and more
White Paper
How to win in the evolving early-stage NSCLC landscape
Strategic considerations to successfully adapt to the rapidly changing NSCLC global market following the introduction of checkpoint inhibitors in resectable disease (non-driver)
-
White Paper
-
Infographic
-
Infographic
-
Blog
-
Webinar
-
Podcast
-
Webinar
-
Podcast
-
Infographic
-
Infographic
Editor's Picks